These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24511554)

  • 1. MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy.
    Gao C; Aqie K; Zhu J; Chen G; Xu L; Jiang L; Xu Y
    J Diabetes Res; 2014; 2014():918396. PubMed ID: 24511554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.
    Huang W; Yang C; Nan Q; Gao C; Feng H; Gou F; Chen G; Zhang Z; Yan P; Peng J; Xu Y
    Biomed Res Int; 2014; 2014():684765. PubMed ID: 25003128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling.
    Xin C; Xia Z; Jiang C; Lin M; Li G
    Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.
    Zhao TT; Zhang HJ; Lu XG; Huang XR; Zhang WK; Wang H; Lan HY; Li P
    PLoS One; 2014; 9(3):e90807. PubMed ID: 24646636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome.
    Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
    Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy.
    Tian Y; Liao F; Wu G; Chang D; Yang Y; Dong X; Zhang Z; Zhang Y; Wu G
    Toxicol Mech Methods; 2015; 25(8):645-52. PubMed ID: 26108275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
    Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
    Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 down-regulation via ubiquitin degradation mediated by Smurf2 in fibroblasts of hypertrophic scars in burned patients.
    Zhang Z; Liu C; Chen B; Tang W; Liu Z; Cao W; Li X
    Burns; 2021 Sep; 47(6):1333-1341. PubMed ID: 33436154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of bone morphogenetic protein-7 and inhibitory Smad expression in streptozotocin-induced diabetic nephropathy rat kidney].
    Yang Q; Han B; Xie RJ; Cheng ML
    Sheng Li Xue Bao; 2007 Apr; 59(2):190-6. PubMed ID: 17437042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of centella asiatica granule on the expression of TGF-β
    Ma JW; Wang HT; Liu HF; Ding Y; Bai JQ; Zhang Z
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):69-73. PubMed ID: 29926663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulatory effect of compound Coptidis Rhizoma capsule on unbalanced expression of renal tissue TGF-β1/BMP-7 and Smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Chen XQ; Tang LQ; Yu N; Zhang XL; Du HF
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):938-45. PubMed ID: 26087560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
    Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
    Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Panax notoginoside on the expression of TGF-β1 and Smad-7 in renal tissues of diabetic rats.
    Tu Q; Qin J; Dong H; Lu F; Guan W
    J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):190. PubMed ID: 21505983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT regulation of mesothelial-to-mesenchymal transition in peritoneal dialysis is modulated by Smurf2 and deubiquitinating enzyme USP4.
    Xiao L; Peng X; Liu F; Tang C; Hu C; Xu X; Wang M; Luo Y; Yang S; Song P; Xiao P; Kanwar YS; Sun L
    BMC Cell Biol; 2015 Mar; 16():7. PubMed ID: 25885904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulatory effect of berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Yu N; Zhang XL; Chen XQ; Tang LQ
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3604-10. PubMed ID: 23477149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
    Pang R; Gu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-β1 signaling pathway.
    Yao Y; Yang J; Wang D; Zhou F; Cai X; Lu W; Hu C; Gu Z; Qian S; Guan X; Cao P
    Phytomedicine; 2013 Oct; 20(13):1160-7. PubMed ID: 23827664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.